Publications by authors named "N K Cetin"
Introduction: Endothelial damage is associated with acute and long-term coronavirus disease 2019 (COVID-19) complications. Proximal nailfold capillaries and nail beds give important clues to microvascular changes associated with endothelial dysfunction.
Objective: We aimed to use dermoscopy to examine the proximal nailfold capillaries and nail bed of COVID-19 patients and identify microvascular changes.
Article Synopsis
- Fanconi anemia (FA) is a genetic condition leading to bone marrow failure, and while hematopoietic stem cell transplantation (HSCT) can provide long-term survival, patients face ongoing health challenges after treatment.
- A study of 36 FA patients who had undergone HSCT showed significant long-term issues, including hormonal imbalances, growth impairments, and signs of metabolic syndrome, highlighting the need for better follow-up care guidelines.
- Key findings included gonadal dysfunction in 35% of patients, pulmonary function issues in nearly half, and a small percentage developing secondary cancers, emphasizing the importance of addressing late effects of HSCT in FA survivors.
Fingolimod is an oral disease-modifying treatment used for the relapsing-remitting forms of multiple sclerosis, which may render patients susceptible to opportunistic infections and lead to an increased risk of skin cancer. We report a 56-year-old woman with multiple sclerosis in remission on fingolimod treatment for five years presenting with the following skin lesions. Our patient presented with a non-healing ulcerated erythematous lesion on the left lower abdomen for six months and a crusted erythematous plaque on the forehead that had not healed for one year.
View Article and Find Full Text PDFBackground/objectives: Eculizumab is a first-line treatment for atypical hemolytic uremic syndrome (aHUS), and patients undergoing eculizumab therapy may become more susceptible to infection caused by (). While meningococcal vaccination is required for patients undergoing eculizumab therapy, there is limited knowledge about meningococcal carriage in children with aHUS. We aimed to evaluate (1) the prevalence of carriage, (2) serogroup distribution, and (3) the immunization status of children undergoing eculizumab treatment for aHUS.
View Article and Find Full Text PDF